238.98 0.00 (0.00%)
After hours: 6:07PM EST
Previous Close | 242.96 |
Open | 245.00 |
Bid | 238.98 x 800 |
Ask | 241.00 x 900 |
Day's Range | 238.78 - 245.99 |
52 Week Range | 139.64 - 247.64 |
Volume | 2,774,929 |
Avg. Volume | 1,089,382 |
Market Cap | 49.844B |
Beta (3Y Monthly) | 0.82 |
PE Ratio (TTM) | 65.62 |
EPS (TTM) | 3.64 |
Earnings Date | Jan 29, 2020 - Feb 3, 2020 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 246.05 |
Edwards Lifesciences uses special equipment catered to fighting heart disease while also focusing on stakeholder capitalism. This enables Edwards Lifesciences to thrive financially and benefit a wider community beyond shareholders. Yahoo Finance’s Adam Shapiro and Julie Hyman discuss with Edwards Lifesciences CEO Mike Mussallem, KPMG Chief Economist Constance Hunter and Just Capital CEO Martin Whittaker on On the Move.
Finding top-performing stocks doesn't have to mean a tradeoff with environmental, social and governance values. Microsoft and Edwards Lifesciences are two top stocks that made IBD's just-released ESG 50 list. Their strong fundamentals and ESG initiatives show up in the chart action.
NuVasive (NUVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Nevro (NVRO) is gaining traction from strengthening international footprint and solid prospects in the SCS market. However, stiff competition remains a woe.
Cooper (COO) gains from solid segmental contributions in fiscal fourth quarter.
Patterson Companies' (PDCO) Q2 results benefit from higher revenues, gross margin expansion and solid show by Dental segment.
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, will discuss the company's strategy for longer-term growth, provide an update on its technology pipeline and share its financial guidance during its annual investor conference today in New York City.
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period […]
Better-than-expected performance at both Medical and Dental segments is likely to have driven Cantel Medical (CMD) in Q1 earnings.
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
HMS Holdings (HMSY) is gaining traction from growing PI and TPM analytical services. However, high debt continues to raise concerns.
Finding strong stocks with solid growth needn't be a tradeoff with your environmental, social and governance values. Check out these 50 Best ESG Companies.
Better-than-expected performance at CVI and CSI, and higher revenues are likely to have aided Cooper Companies (COO) in Q4 earnings.
If two heads are better than one, then surely three heads are better than two when it comes to a mutual fund's search for top growth stocks.
When to buy stocks at the right time? Learn key chart patterns in the best growth stocks to spot the breakout. Next, check out these follow-on entry points.
The S&P 500 Health Care index has underperformed the market in 2019, up 15.2% to the S&P 500’s 25.8%. Shares of Edwards Lifesciences, which sells heart valves and monitoring equipment, are up 60.8% so far this year. In August, the Food and Drug Administration approved two Edwards devices, SAPIEN 3 and SAPIEN 3 Ultra, for a broader set of patients, following the release of positive trial results earlier in the year.
Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Robust product portfolio and higher revenues are likely to have benefited Veeva Systems (VEEV) in third-quarter fiscal 2020 earnings.
Edwards Lifesciences, Fossil, United Airlines and Boeing highlighted as Zacks Bull and Bear of the Day
Looking for good ESG stocks to consider? This list shows those with the best stock performance ratings in their industry category, from tech to real estate.
When it comes to ESG investing, Edwards Lifesciences stock is a leader. But the medical technology company says those standards are just core to its mission.
Edwards Lifesciences (EW) issues a product recall for its guide sheath based on report from its urgent field safety notice.